Skip to content

Search

WA Aboriginal Health Knowledge Network

A Network comprised of four regional sites to facilitate key medical, research and training activities undertaken in partnership with Aboriginal communities.

WAACHS Regional Profiles

The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.

Aboriginal and Torres Strait Islander Suicide Prevention Evaluation Project (ATSISPEP)

The NATSISPEP will formally evaluate a range of existing Indigenous suicide prevention programs and services to develop an evidence base for 'what works'.

Our research

At The Kids Research Institute Australia, we've been thinking of the kids for 35 years. We are finding the answers to some of the biggest problems facing the health and wellbeing of children and families. Our Research Themes host defined programs of work where the Institute has clear strengths and capacity. Our overarching commitment to First Nations Health and Equity is embedded across all our work and features as a core consideration in each Research Theme. The Institute is committed to ending the disparity in health and wellbeing outcomes between Aboriginal and non-Aboriginal kids and families.

CRE in Aboriginal Health and Wellbeing (CREAHW)

CREAHW is a program of intervention research focused on achieving sustainable change for the Aboriginal community & improving the lives of Aboriginal people.

The Kids Kimberley

The aim of establishing a local presence is based upon an intention to be by invitation considered as part of the Kimberley group of organisations as well ...

Indigenous Capacity Building Grant (ICBG)

This was a five year grant from the NHMRC to build research capacity in ten Aboriginal researchers

Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia

Two RSV immunisations products: a maternal vaccine, Abrysvo, and a long-acting monoclonal antibody, nirsevimab, both designed to prevent RSV illness in infants, have recently become available. Modelling evidence is required to inform how to optimally use these products in immunisation programs to reduce the burden of RSV in young children.

Early rheumatic heart disease is a recognized intermediate on the pathway to advanced rheumatic heart disease

Rheumatic heart disease is a major cause of premature cardiovascular morbidity and mortality globally. Over the past decade, echocardiographic screening has changed our understanding of the natural history of RHD, revealing a high burden of clinically silent, mild RHD among people who cannot recall a history of preceding acute rheumatic fever. This viewpoint outlines the evidence that this earliest form of rheumatic heart disease, only detectable through echocardiographic screening, is an intermediate stage that many, but not all, individuals may pass through on the pathway to advanced rheumatic heart disease.